Brief: Vericel Expects FY Revenue $180-$188 Million
23/02/2023 12:58
Feb 23 (Reuters) - Vericel Q4 adjusted EBITDA USD 14.9 million. * Q4 gross margin 73% * Q4 net income USD 5.9 million * Outlook FY revenue USD 180-188 million * Q4 gross profit USD 38.249 million
Recent news on Vericel
See all newsMedTech growth concerns likely to overshadow Q3 results, Leerink says
Vericel Corp reports results for the quarter ended June 30 - Earnings Summary
Vericel beats Q2 revenue estimates, boosts annual outlook
Brief: Vericel Q2 EPS USD 0.04
Vericel beats Q1 revenue on MACI, burn care growth, lifts 2026 sales outlook